Fenofibrate-L-threonine Derivative (Lipicard)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameFenofibrate-L-threonine Derivative (Lipicard)
Drug Alias NamePeroxibrate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipicard Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipicard Technologies
Active IndicationsN/A
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A